Skip to content
healthcare.dev

VYLOY

NDC 0469-3425, ZOLBETUXIMAB, injection, powder, for suspension, from Astellas Pharma US, Inc..

Product NDC
0469-3425
Status
Listed
Labeler
Astellas Pharma US, Inc.
Dosage form
INJECTION, POWDER, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761365
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0469-3425 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZOLBETUXIMAB20 mg/mL

Pharmacologic classes

Claudin 18.2-directed Antibody Interactions [MoA]; Claudin 18.2-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package
0469-3425-10004693425101 VIAL in 1 BOX (0469-3425-10) / 5 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e7695a21-abb6-47ac-93f8-0ece5a9c4409
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0469-3425

Use it

Look up 0469-3425 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0469-3425 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0469-3425. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.